In 2014 the healthcare industry saw fundamental change in how health plans approach the market, provider consolidation in many areas, a focus on quality-based payments, unprecedented growth in consumer liability for the cost of chronic illness, and a slowing in the rise in healthcare costs.
What are the practical implications for strategy? What can we expect in 2015 with new markets and new decision makers? Join us for a one-hour discussion on these issues and their implications.
- New sources of insurance – both individual and consumer-directed – and how changes in benefit design are affecting consumer choices.
- Quality-based payments – how they are being crafted and how they are affecting the type of healthcare prioritized by plans.
- Change at the FDA, including biosimilars approvals, and stakeholder and patient voice. And how legislation may affect the FDA mission.
- The likely future of the Affordable Care Act (ACA) given a new political configuration and the start of a new political season.
- Next steps for innovative health system models, including commercial contracts, Medicare shared savings, Accountable Care Organization (ACO) rulemaking.
Space is limited, so register today.
Other panelists include: Lindy Hinman, Senior Vice President; Ellen Lukens, Vice President; and Josh Seidman, Vice President.